The following 10 learnings highlight the ways in which the COVAX Humanitarian Buffer (HB) and COVAX’s broader learnings in reaching humanitarian settings can contribute to both the Alliance’s work in routine immunisation, future preparedness and…

The policy that guides Gavi’s support to health system and immunisation strengthening (HSIS). The purpose of the HSIS policy, in effect from January 2023, is to set out the principles, general requirements and procedures for Gavi’s HSIS…

In 2021, we launched a new strategy with ambitious goals and targets.

Delivered by Gavi and partners in response to a call from the African Union and G7 Development Ministers

The COVID-19 pandemic has demonstrated the clear need for the world to be better prepared the next time a public health emergency of this scale strikes. Rapid and equitable global access to medical interventions, such as therapeutics, diagnostics…

Addressing the most unpredictable and hard-to-fill gaps in access.

One of the prominent issues exposed by the COVID-19 pandemic is the urgent need to further diversify global vaccine manufacturing, particularly with regards to Africa. With the political realities of nationalism, trade barriers, and the absence…

COVAX was launched in 2020 with equity as its foundational principle, and fundamental to its design from the outset was a vision to address the most unpredictable and hardest to fill gaps in global COVID-19 vaccine access.

The Learning System is an approach that enables use of data and evidence to strengthen delivery of Gavi’s strategies, policies, and programmes.

Welcome to Gavi’s 2021 Annual Progress Report, the first of the 2021–2025 strategic period.